Preclinical studies, including findings from the HAB/LAB rat model [18]–[21] and voles [22], as well as clinical observations [23] support a direct involvement of centrally released AVP in anxiety/depression-like behaviors and disorders. This evidence concerns the gene AVP and depressive symptom measurement.